Form 8-K HCA Healthcare, Inc. For: Jan 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
January 27, 2025 11:46 AM ESTMizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).
The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More
HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners
January 27, 2025 6:23 AM ESTLeerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More
